Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 1, Pages 104
Publisher
MDPI AG
Online
2017-01-06
DOI
10.3390/ijms18010104
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of Aberrant MicroRNA-133a Expression in Endothelial Cells by Statin Prevents Endothelial Dysfunction by Targeting GTP Cyclohydrolase 1 in VivoClinical Perspective
- (2016) Peng Li et al. CIRCULATION
- Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association
- (2016) Barbara S. Wiggins et al. CIRCULATION
- Pharmacogenetics of Lipid-Lowering Agents: Precision or Indecision Medicine?
- (2016) Jeffrey E. Alfonsi et al. Current Atherosclerosis Reports
- Genetic and Non-Genetic Determinants of the Pharmacological Activity of Statins
- (2016) Marta Karazniewicz-Lada et al. CURRENT DRUG METABOLISM
- Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells
- (2016) Alice C. Rodrigues et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview
- (2016) Elena Arrigoni et al. Expert Opinion on Drug Metabolism & Toxicology
- The safety of ezetimibe and simvastatin combination for the treatment of hypercholesterolemia
- (2016) Anastazia A. Kei et al. Expert Opinion On Drug Safety
- Effect of vildagliptin and pravastatin combination on cholesterol efflux in adipocytes
- (2016) Ahmed M. Mostafa et al. IUBMB LIFE
- Genetic determinants of lipid-lowering response to atorvastatin therapy in an Indian population
- (2016) P. Kadam et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Meta-analysis of genome-wide association studies of HDL cholesterol response to statins
- (2016) Iris Postmus et al. JOURNAL OF MEDICAL GENETICS
- Risks of Adverse Events Following Coprescription of Statins and Calcium Channel Blockers
- (2016) Yi-Chun Wang et al. MEDICINE
- Pharmacogenomics of Rosuvastatin: A Glocal (Global+Local) African Perspective and Expert Review on a Statin Drug
- (2016) Nyarai D. Soko et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Seventeen years of statin pharmacogenetics: a systematic review
- (2016) Maarten Leusink et al. PHARMACOGENOMICS
- Pitavastatin Differentially Modulates MicroRNA-Associated Cholesterol Transport Proteins in Macrophages
- (2016) Haijun Zhang et al. PLoS One
- Do statins really cause diabetes? A meta-analysis of major randomized controlled clinical trials
- (2016) Alaa Rahal et al. SAUDI MEDICAL JOURNAL
- Modulation of microRNA Expression in Subjects with Metabolic Syndrome and Decrease of Cholesterol Efflux from Macrophages via microRNA-33-Mediated Attenuation of ATP-Binding Cassette Transporter A1 Expression by Statins
- (2016) Wei-Ming Chen et al. PLoS One
- Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study
- (2016) Asita Wongprikorn et al. PLoS One
- Comparison of the Risk of Gastrointestinal Bleeding among Different Statin Exposures with Concomitant Administration of Warfarin: Electronic Health Record-Based Retrospective Cohort Study
- (2016) Dahye Shin et al. PLoS One
- Drug Interactions with the Direct-Acting Antiviral Combination of Ombitasvir and Paritaprevir-Ritonavir
- (2015) Prajakta S. Badri et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Altered microRNome Profiling in Statin-Induced HepG2 Cells: A Pilot Study Identifying Potential new Biomarkers Involved in Lipid-Lowering Treatment
- (2015) Tomás Zambrano et al. CARDIOVASCULAR DRUGS AND THERAPY
- Interactions Between CYP3A5*3 and POR*28 Polymorphisms and Lipid Lowering Response with Atorvastatin
- (2015) Kan-kan Wei et al. CLINICAL DRUG INVESTIGATION
- CYP2C9 Genetic Polymorphism is a Potential Predictive Marker for the Efficacy of Rosuvastatin Therapy
- (2015) Jiayao Lin et al. Clinical Laboratory
- Physiologically based pharmacokinetic modeling of disposition and drug–drug interactions for atorvastatin and its metabolites
- (2015) Tao Zhang EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Drug–drug interactions that interfere with statin metabolism
- (2015) Takeshi Hirota et al. Expert Opinion on Drug Metabolism & Toxicology
- HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
- (2015) Daniel I Swerdlow et al. LANCET
- ABCB1 C3435T polymorphism and the lipid-lowering response in hypercholesterolemic patients on statins: a meta-analysis
- (2015) Jia Su et al. Lipids in Health and Disease
- Association Between SLCO1B1 Gene T521C Polymorphism and Statin-Related Myopathy Risk
- (2015) Qingtao Hou et al. MEDICINE
- SLCO1B1 polymorphism markedly affects the pharmacokinetics of lovastatin acid
- (2015) Aleksi Tornio et al. Pharmacogenetics and Genomics
- Impact of CYP2D6, CYP3A5, CYP2C19, CYP2A6, SLCO1B1, ABCB1, and ABCG2 gene polymorphisms on the pharmacokinetics of simvastatin and simvastatin acid
- (2015) Hee Youn Choi et al. Pharmacogenetics and Genomics
- ABCG2gene polymorphisms as risk factors for atorvastatin adverse reactions: a case–control study
- (2015) Nikica Mirošević Skvrce et al. PHARMACOGENOMICS
- Epigenetic-related therapeutic challenges in cardiovascular disease
- (2015) Concetta Schiano et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Possible association of ABCB1:c.3435T>C polymorphism with high-density-lipoprotein-cholesterol response to statin treatment - a pilot study.
- (2015) Anna Sałacka et al. Bosnian Journal of Basic Medical Sciences
- Inflammation and lipid profile in rheumatoid arthritis: bridging an apparent paradox
- (2014) Miguel A González-Gay et al. ANNALS OF THE RHEUMATIC DISEASES
- Role of microRNAs 221/222 on Statin Induced Nitric Oxide Release in Human Endothelial Cells
- (2014) Alvaro Cerda et al. Arquivos Brasileiros de Cardiologia
- Rosuvastatin May Reduce the Incidence of Cardiovascular Events in Patients with Acute Coronary Syndromes Receiving Percutaneous Coronary Intervention by Suppressing miR-155/SHIP-1 Signaling Pathway
- (2014) Wenchao Xie et al. Cardiovascular Therapeutics
- Pharmacogenomics, Lipid Disorders, and Treatment Options
- (2014) S E Gryn et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- POR*28SNP is associated with lipid response to atorvastatin in children and adolescents with familial hypercholesterolemia
- (2014) Euridiki Drogari et al. PHARMACOGENOMICS
- No association between CYP3A4*22 and statin effectiveness in reducing the risk for myocardial infarction
- (2014) Maarten Leusink et al. PHARMACOGENOMICS
- Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins
- (2014) Iris Postmus et al. Nature Communications
- What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice
- (2014) Judith A Finegold et al. European Journal of Preventive Cardiology
- Narrative Review: Statin-Related Myopathy
- (2013) Tisha R. Joy ANNALS OF INTERNAL MEDICINE
- Inflammatory Stress Induces Statin Resistance by Disrupting 3-Hydroxy-3-Methylglutaryl-CoA Reductase Feedback Regulation
- (2013) Yaxi Chen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Statin use and risk of kidney cancer: a meta-analysis of observational studies and randomized trials
- (2013) Xiao-long Zhang et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Working Group Consensus Update
- (2013) G.B. John Mancini et al. CANADIAN JOURNAL OF CARDIOLOGY
- Statin use and risk of bladder cancer: a meta-analysis
- (2013) Xiao-long Zhang et al. CANCER CAUSES & CONTROL
- Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies
- (2013) Yanqiong Liu et al. CANCER CAUSES & CONTROL
- Comparative Tolerability and Harms of Individual Statins
- (2013) Huseyin Naci et al.
- Statins Are Associated With Reduced Risk of Esophageal Cancer, Particularly in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis
- (2013) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- SLCO1B1 Genetic Variant Associated With Statin-Induced Myopathy: A Proof-of-Concept Study Using the Clinical Practice Research Datalink
- (2013) D F Carr et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Statin therapy correlated CYP2D6 gene polymorphism and hyperlipidemia
- (2013) Juyi Li et al. CURRENT MEDICAL RESEARCH AND OPINION
- Statins are associated with reduced risk of gastric cancer: A meta-analysis
- (2013) Xiao-Dan Wu et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin
- (2013) Miao Hu et al. Expert Opinion on Drug Metabolism & Toxicology
- Absence of Clinically Relevant Interactions between Rivaroxaban - an Oral, Direct Factor Xa Inhibitor - and Digoxin or Atorvastatin in Healthy Subjects
- (2013) D Kubitza et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Lipid-lowering effect of fluvastatin in relation to cytochrome P450 2C9 variant alleles frequently distributed in the Czech population
- (2013) Helena Buzkova et al. MEDICAL SCIENCE MONITOR
- Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm
- (2013) Jamie Robertson et al. Nature Reviews Rheumatology
- CYP2C9andABCG2polymorphisms as risk factors for developing adverse drug reactions in renal transplant patients taking fluvastatin: a case–control study
- (2013) Nikica Miroševic Skvrce et al. PHARMACOGENOMICS
- Statins and the Risk of Lung Cancer: A Meta-Analysis
- (2013) Min Tan et al. PLoS One
- Statin use and risk of breast cancer: a meta-analysis of observational studies
- (2012) Krishna Undela et al. BREAST CANCER RESEARCH AND TREATMENT
- Statin use and risk of pancreatic cancer: a meta-analysis
- (2012) Xiaobing Cui et al. CANCER CAUSES & CONTROL
- Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction
- (2012) Daniel I. Chasman et al. Circulation-Cardiovascular Genetics
- The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy
- (2012) R A Wilke et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Impact of ABCC2, ABCG2 and SLCO1B1 Polymorphisms on the Pharmacokinetics of Pitavastatin in Humans
- (2012) Eun Sil Oh et al. Drug Metabolism and Pharmacokinetics
- miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity
- (2012) Ryan M. Allen et al. EMBO Molecular Medicine
- Statins and primary liver cancer
- (2012) Danitza Pradelli et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Pharmacokinetic interaction studies of co-administration of ticagrelor and atorvastatin or simvastatin in healthy volunteers
- (2012) Renli Teng et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The Controversies of Statin Therapy
- (2012) J. Wouter Jukema et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pharmacogenetics of statins: achievements, whole-genome analyses and future perspectives
- (2012) Iris Postmus et al. PHARMACOGENOMICS
- CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapy
- (2012) Laure Elens et al. PHARMACOGENOMICS
- Genome-Wide Study of Gene Variants Associated with Differential Cardiovascular Event Reduction by Pravastatin Therapy
- (2012) Dov Shiffman et al. PLoS One
- Statin Use and Risk of Prostate Cancer: A Meta-Analysis of Observational Studies
- (2012) Dipika Bansal et al. PLoS One
- Meta-Analyses of KIF6 Trp719Arg in Coronary Heart Disease and Statin Therapeutic Effect
- (2012) Ping Peng et al. PLoS One
- Clinical response to statins: Mechanism(s) of variable activity and adverse effects
- (2011) Cesare R. Sirtori et al. ANNALS OF MEDICINE
- The Role of OATP1B1 and BCRP in Pharmacokinetics and DDI of Novel Statins
- (2011) Wen Jin Hua et al. Cardiovascular Therapeutics
- A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application?
- (2011) Jeffrey J.W. Verschuren et al. EUROPEAN HEART JOURNAL
- Effect of linagliptin (BI 1356) on the steady-state pharmacokinetics of simvastatin
- (2011) U. Graefe-Mody et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- The C3435T polymorphism in ABCB1 influences atorvastatin efficacy and muscle symptoms in a high-risk vascular cohort
- (2011) Michel R. Hoenig et al. Journal of Clinical Lipidology
- Cerivastatin, genetic variants, and the risk of rhabdomyolysis
- (2011) Kristin D. Marciante et al. Pharmacogenetics and Genomics
- Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin
- (2011) L R Brunham et al. PHARMACOGENOMICS JOURNAL
- Genetic variation in the ABCC2 gene is associated with dose decreases or switches to other cholesterol-lowering drugs during simvastatin and atorvastatin therapy
- (2011) M L Becker et al. PHARMACOGENOMICS JOURNAL
- Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
- (2011) M. Niemi et al. PHARMACOLOGICAL REVIEWS
- Hepatic Metabolism and Transporter Gene Variants Enhance Response to Rosuvastatin in Patients With Acute Myocardial Infarction
- (2010) Kristian M. Bailey et al. Circulation-Cardiovascular Genetics
- Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I
- (2010) Christine E. Staatz et al. CLINICAL PHARMACOKINETICS
- Common Nonsynonymous Substitutions in SLCO1B1 Predispose to Statin Intolerance in Routinely Treated Individuals With Type 2 Diabetes: A Go-DARTS Study
- (2010) L A Donnelly et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- ABCG2 Polymorphism Is Associated With the Low-Density Lipoprotein Cholesterol Response to Rosuvastatin
- (2010) B Tomlinson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Expression ofmiR-146a/bis associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin–angiotensin system blockade and statins onmiRNA-146a/band Toll-like receptor 4 levels
- (2010) Yuji Takahashi et al. CLINICAL SCIENCE
- The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins
- (2010) Miao Hu et al. Expert Opinion on Drug Metabolism & Toxicology
- Efflux and uptake transporters as determinants of statin response
- (2010) Alice C Rodrigues Expert Opinion on Drug Metabolism & Toxicology
- Treatment of dyslipidemia in HIV-infected patients
- (2010) Rajagopal V Sekhar et al. EXPERT OPINION ON PHARMACOTHERAPY
- Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients
- (2010) Miao Hu et al. Pharmacogenetics and Genomics
- Genome-Wide Association of Lipid-Lowering Response to Statins in Combined Study Populations
- (2010) Mathew J. Barber et al. PLoS One
- MiR-33 Contributes to the Regulation of Cholesterol Homeostasis
- (2010) K. J. Rayner et al. SCIENCE
- Statin Adverse Effects
- (2009) Beatrice A Golomb et al. American Journal of Cardiovascular Drugs
- Identification of Genetic Variants Associated With Response to Statin Therapy
- (2009) Jessica L. Mega et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Statins Control Oxidized LDL-Mediated Histone Modifications and Gene Expression in Cultured Human Endothelial Cells
- (2009) Philippe Dje N'Guessan et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Impact of OATP transporters on pharmacokinetics
- (2009) A Kalliokoski et al. BRITISH JOURNAL OF PHARMACOLOGY
- Comprehensive Whole-Genome and Candidate Gene Analysis for Response to Statin Therapy in the Treating to New Targets (TNT) Cohort
- (2009) John F. Thompson et al. Circulation-Cardiovascular Genetics
- Transporter Pharmacogenetics and Statin Toxicity
- (2009) M Niemi CLINICAL PHARMACOLOGY & THERAPEUTICS
- ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin
- (2009) J E Keskitalo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pitavastatin Attenuates Leukocyte-Endothelial Interactions Induced by Ischemia-Reperfusion Injury in the Rat Retina
- (2009) Kenichi Miyaki et al. CURRENT EYE RESEARCH
- Metabolism and Excretion of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor, in Rats, Dogs, and Humans
- (2009) C. Weinz et al. DRUG METABOLISM AND DISPOSITION
- Effect of atorvastatin on microRNA 221 / 222 expression in endothelial progenitor cells obtained from patients with coronary artery disease
- (2009) Y. Minami et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs
- (2009) Ichiro Ieiri et al. Expert Opinion on Drug Metabolism & Toxicology
- The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects
- (2009) Deepak Voora et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Influence of genetic variation inCYP3A4andABCB1on dose decrease or switching during simvastatin and atorvastatin therapy
- (2009) Matthijs L. Becker et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Common genetic variation in theABCB1gene is associated with the cholesterol-lowering effect of simvastatin in males
- (2009) Matthijs L Becker et al. PHARMACOGENOMICS
- Different effects of theABCG2c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin
- (2009) Jenni E Keskitalo et al. PHARMACOGENOMICS
- Statin regulation of CYP3A4 and CYP3A5 expression
- (2009) Maria Alice Vieira Willrich et al. PHARMACOGENOMICS
- APOE gene polymorphisms and response to statin therapy
- (2009) E Zintzaras et al. PHARMACOGENOMICS JOURNAL
- Epigenetics: Definition, Mechanisms and Clinical Perspective
- (2009) Cathérine Dupont et al. SEMINARS IN REPRODUCTIVE MEDICINE
- Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER
- (2008) Eliana Polisecki et al. ATHEROSCLEROSIS
- ABCB1 and ABCC1 expression in peripheral mononuclear cells is influenced by gene polymorphisms and atorvastatin treatment
- (2008) Ivanise Marina Moretti Rebecchi et al. BIOCHEMICAL PHARMACOLOGY
- Variation in the 3-Hydroxyl-3-Methylglutaryl Coenzyme A Reductase Gene Is Associated With Racial Differences in Low-Density Lipoprotein Cholesterol Response to Simvastatin Treatment
- (2008) Ronald M. Krauss et al. CIRCULATION
- Involvement of Multiple Transporters in the Hepatobiliary Transport of Rosuvastatin
- (2008) S. Kitamura et al. DRUG METABOLISM AND DISPOSITION
- CETP genotype predicts increased mortality in statin-treated men with proven cardiovascular disease: an adverse pharmacogenetic interaction
- (2008) J. J. Regieli et al. EUROPEAN HEART JOURNAL
- Association of Cholesteryl Ester Transfer Protein Genotypes With CETP Mass and Activity, Lipid Levels, and Coronary Risk
- (2008) Alexander Thompson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Polymorphism in KIF6 Gene and Benefit From Statins After Acute Coronary Syndromes
- (2008) Olga A. Iakoubova et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- The effect of SLCO1B1*15 on the disposition of pravastatin and pitavastatin is substrate dependent: the contribution of transporting activity changes by SLCO1B1*15
- (2008) Jian Wei Deng et al. Pharmacogenetics and Genomics
- A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study
- (2008) Louise A. Donnelly et al. Pharmacogenetics and Genomics
- Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease
- (2008) Tuomo Nieminen et al. PHARMACOGENOMICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started